医学
肾移植
药品
免疫抑制剂
肾
肾移植
重症监护医学
免疫抑制
内科学
药理学
移植
作者
John S. Gill,Richard N. Formica,Barbara Murphy
出处
期刊:Journal of The American Society of Nephrology
日期:2021-03-02
卷期号:32 (4): 774-776
被引量:12
标识
DOI:10.1681/asn.2020121811
摘要
Beginning in 2023, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534; also known as the Immuno bill) will add a new Medicare option solely to cover immunosuppressive drugs for kidney transplant recipients.[1][1] Patients may enroll beginning 36 months
科研通智能强力驱动
Strongly Powered by AbleSci AI